BioLineRx Ltd.
AGI-134 COMBINED WITH A CHECKPOINT INHIBITOR FOR THE TREATMENT OF SOLID TUMORS
Last updated:
Abstract:
A method of treating a tumor in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of: i) Pembrolizumab; and ii) a lipid having a structural formula as illustrated in FIG. 1 (AGI-134).
Status:
Application
Type:
Utility
Filling date:
27 May 2019
Issue date:
29 Apr 2021